Wang Jing,Tu Dehua,Li Bo,et al.. The incidence of the adverse reactions of the first-line anti-tuberculosis drugs in Beijing and its influence on the chemotherapy[J]. Chinese Journal of Antituberculosis, 2008, 30(4): 271-274.
1 屠德华.试论耐药结核病的发生[J].中华结核和呼吸杂志,2007,30(6):403-405
2 中华人民共和国卫生部、国家食品药品监督管理局.药品不良反应报告和监测管理办法[M].北京:社会科学文献出版社,2004:3
3 Marra F, Marra CA,Bruchet N,et al. Adverse drug reactions associated with first-line anti-tuberculosis drug regimens [J].INTJ Tuberc Lung Dis, 2007,11 (8) :868-875
4 夏愔愔,詹思延.国内抗结核药不良反应发生率的综合分析[J].中华结核和呼吸杂志,2007,30(6):419-423
5 Yee D, Valiquette C, Pelletier M,et al. Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis[J]. Am J respir Crit Care Med,2003,167:1472-1477
6 Ungo JR. Jones D, Ashkin D, et al. Antituberculosis drug-induced hepatotoxicity[J]. Am J respir Crit Care Med, 1998,157:1871-1876
7 蔡雄茂,姚思敏,付向东,等.抗结核药致急性肝功能衰竭死亡11例临床分析[J].中国防痨杂志,2003,25(6) :140-142